DIPHENHYDRAMINE CITRATE, IBUPROFEN

N/A

Manufactured by Family Dollar (FAMILY WELLNESS)

188 FDA adverse event reports analyzed

Last updated: 2026-04-15

About DIPHENHYDRAMINE CITRATE, IBUPROFEN

DIPHENHYDRAMINE CITRATE, IBUPROFEN is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Family Dollar (FAMILY WELLNESS). The most commonly reported adverse reactions for DIPHENHYDRAMINE CITRATE, IBUPROFEN include FATIGUE, NAUSEA, COMPLETED SUICIDE, ABDOMINAL DISTENSION, HYPOAESTHESIA. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for DIPHENHYDRAMINE CITRATE, IBUPROFEN.

Top Adverse Reactions

FATIGUE8 reports
NAUSEA8 reports
COMPLETED SUICIDE5 reports
ABDOMINAL DISTENSION4 reports
HYPOAESTHESIA4 reports
INSOMNIA4 reports
JOINT SWELLING4 reports
PRODUCT USE IN UNAPPROVED INDICATION4 reports
VOMITING4 reports
ABDOMINAL PAIN3 reports
ARTHROPATHY3 reports
COLD SWEAT3 reports
CONSTIPATION3 reports
DIARRHOEA3 reports
DIZZINESS3 reports
DRUG EFFECTIVE FOR UNAPPROVED INDICATION3 reports
HEADACHE3 reports
HOT FLUSH3 reports
MALAISE3 reports
PAIN3 reports
PRURITUS3 reports
SOMNOLENCE3 reports
TOXICITY TO VARIOUS AGENTS3 reports
ALOPECIA2 reports
ARTHRALGIA2 reports
ARTHRITIS2 reports
BALANCE DISORDER2 reports
CEREBROVASCULAR ACCIDENT2 reports
CHEST DISCOMFORT2 reports
CHEST PAIN2 reports
CONFUSIONAL STATE2 reports
FEELING ABNORMAL2 reports
FLUSHING2 reports
HERPES ZOSTER2 reports
HYPERSENSITIVITY2 reports
IMPAIRED WORK ABILITY2 reports
MUSCLE SPASMS2 reports
PALLOR2 reports
PARAESTHESIA2 reports
PERIPHERAL SWELLING2 reports
PRODUCT DOSE OMISSION2 reports
RASH2 reports
SEIZURE2 reports
TINNITUS2 reports
UPPER RESPIRATORY TRACT INFECTION2 reports
VISUAL IMPAIRMENT2 reports
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS2 reports
ACCIDENTAL EXPOSURE TO PRODUCT1 reports
ACNE1 reports
ANAEMIA1 reports
ARTERIOSCLEROSIS1 reports
ASTHENIA1 reports
BACK INJURY1 reports
BLINDNESS UNILATERAL1 reports
BLOOD GLUCOSE INCREASED1 reports
BLOOD PRESSURE ABNORMAL1 reports
BLOODY DISCHARGE1 reports
BONE PAIN1 reports
BRADYCARDIA1 reports
BRAIN OEDEMA1 reports
BRONCHOPNEUMONIA1 reports
CATARACT1 reports
CERVICAL RADICULOPATHY1 reports
CHILLS1 reports
COGNITIVE DISORDER1 reports
COLITIS1 reports
COLITIS ULCERATIVE1 reports
COMMUNICATION DISORDER1 reports
CONDITION AGGRAVATED1 reports
CORONARY ARTERY STENOSIS1 reports
COUGH1 reports
CRYING1 reports
CYSTITIS1 reports
DEVICE DISLOCATION1 reports
DEVICE LEAKAGE1 reports
DISORIENTATION1 reports
DISTURBANCE IN ATTENTION1 reports
DRUG ABUSE1 reports
DRUG DEPENDENCE1 reports
DRUG EFFECT DECREASED1 reports
DRUG EFFECT PROLONGED1 reports
DRUG INEFFECTIVE1 reports
DRY MOUTH1 reports
DUODENAL ULCER1 reports
DYSGEUSIA1 reports
DYSPNOEA1 reports
ENDODONTIC PROCEDURE1 reports
EYE DISORDER1 reports
FALL1 reports
FOAMING AT MOUTH1 reports
FOETAL EXPOSURE DURING PREGNANCY1 reports
GAIT DISTURBANCE1 reports
GAIT INABILITY1 reports
GASTRIC ULCER1 reports
GASTRIC ULCER HAEMORRHAGE1 reports
GASTRITIS1 reports
GASTROINTESTINAL HAEMORRHAGE1 reports
GASTROOESOPHAGEAL REFLUX DISEASE1 reports
HAEMORRHAGIC ANAEMIA1 reports
HALLUCINATION1 reports

Report Outcomes

Out of 76 classified reports for DIPHENHYDRAMINE CITRATE, IBUPROFEN:

Serious 43.4%Non-Serious 56.6%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female41 (62.1%)
Male24 (36.4%)
Unknown1 (1.5%)

Reports by Age

Age 554 reports
Age 654 reports
Age 413 reports
Age 603 reports
Age 542 reports
Age 572 reports
Age 582 reports
Age 592 reports
Age 682 reports
Age 211 reports
Age 281 reports
Age 321 reports
Age 331 reports
Age 341 reports
Age 351 reports
Age 391 reports
Age 491 reports
Age 511 reports
Age 611 reports
Age 641 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with DIPHENHYDRAMINE CITRATE, IBUPROFEN?

This profile reflects 188 FDA FAERS reports that mention DIPHENHYDRAMINE CITRATE, IBUPROFEN. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for DIPHENHYDRAMINE CITRATE, IBUPROFEN?

Frequently reported terms in FAERS include FATIGUE, NAUSEA, COMPLETED SUICIDE, ABDOMINAL DISTENSION, HYPOAESTHESIA, INSOMNIA. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures DIPHENHYDRAMINE CITRATE, IBUPROFEN?

Labeling and FAERS entries often list Family Dollar (FAMILY WELLNESS) in connection with DIPHENHYDRAMINE CITRATE, IBUPROFEN. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.